daclizumab
0 sources
daclizumab
Summary
daclizumab is a type of chemical entity[1]. daclizumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (27 views/month).[2]
Key Facts
- daclizumab's instance of is recorded as type of chemical entity[3].
- daclizumab's CAS Registry Number is recorded as 152923-56-3[4].
- daclizumab's ATC code is recorded as L04AC01[5].
- daclizumab's Bibliothèque nationale de France ID is recorded as 14456549m[6].
- daclizumab's IdRef ID is recorded as 069771197[7].
- daclizumab's subclass of is recorded as chemical compound[8].
- daclizumab's has use is recorded as medication[9].
- daclizumab's MeSH descriptor ID is recorded as D000077561[10].
- daclizumab's has part is recorded as carbon[11].
- daclizumab's ChEMBL ID is recorded as CHEMBL1201605[12].
- daclizumab's Guide to Pharmacology Ligand ID is recorded as 6880[13].
- daclizumab's Freebase ID is recorded as /m/02m3ps[14].
- daclizumab's UNII is recorded as CUJ2MVI71Y[15].
- daclizumab's MeSH tree code is recorded as D12.776.124.486.485.114.224.060.766[16].
- daclizumab's MeSH tree code is recorded as D12.776.124.790.651.114.224.060.766[17].
- daclizumab's MeSH tree code is recorded as D12.776.377.715.548.114.224.200.766[18].
- daclizumab's DrugBank ID is recorded as DB00111[19].
- daclizumab's has characteristic is recorded as biopharmaceutical[20].
- daclizumab's NDF-RT ID is recorded as N0000148541[21].
- daclizumab's UNSPSC code is recorded as 51201509[22].
- daclizumab's medical condition treated is recorded as graft-versus-host disease[23].
- daclizumab's medical condition treated is recorded as relapsing-remitting multiple sclerosis[24].
- daclizumab's medical condition treated is recorded as multiple sclerosis[25].
- daclizumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'daclizumab'}[26].
- daclizumab's NSC number is recorded as 725173[27].
Why It Matters
daclizumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (27 views/month).[2] daclizumab has Wikipedia articles in 11 language editions, a strong signal of global cultural recognition.[28] daclizumab is known by 9 alternative names across languages and contexts.[29]